BarbriSFCourseDetails

Course Details

This CLE course will guide counsel for companies in the medical device industry on protecting software as a medical device (SaMD). The panel will discuss the FDA rules regulating SaMD and how to leverage IP law to protect SaMD.

Faculty

Description

SaMD is rapidly growing, ranging from wearable activity tracking devices to smartphone apps that view images obtained from an MRI for diagnostic purposes. Further, the FDA rules delineate the regulatory requirements for SaMD.

With new technologies and products introduced every day, companies and counsel want maximum protection for SaMD. Patent, design patent, trade secrets, and other forms of IP are increasingly crucial to SaMD innovators due to the significant investments needed to withstand FDA scrutiny under the guidelines. However, what is patent eligible in the context of software-related inventions is not always clear.

Listen as our authoritative panel of patent attorneys discusses software as a medical device and the FDA rules regulating SaMD. The panel will examine what IP rights are available for SaMD, outline how to protect SaMD, and offer insights into examining IP rights and limitations applications.

Outline

  1. Software-as-a-Medical Device (SaMD) and Software-in-a-Medical Device (SiMD) defined
  2. Examples of SaMD/SiMD FDA regulation 
  3. Protecting SaMD and SiMD inventions
    • Patent prosecution
      • Prosecution including patentable subject matter; drafting and prosecution techniques, discussion of recent relevant cases
    • Patent Enforcement
      • Enforcement: type of litigation (competitor vs. competitor; NPE)
      • Pitfalls (e.g., joint infringement issues, early motions based on Alice)
      • Remedies and settlement
    • Other Enforcement options
      • Trade secrets
      • Design patent (Techniques for protecting products, replacement parts, and user interfaces)
      • Trade dress: development of trade dress rights, recent cases
      • Copyright
        • Role of open source licenses
  4. Joint Development and Collaboration Agreements
    • Licensing Rights
    • Protecting ownership
  5. Artificial Intelligence considerations
    • IP considerations
    • FDA considerations

Benefits

The panel will review these and other key issues:

  • Learn about new developments in Artificial Intelligence and considerations by the FDA
  • What are key issues when engaging in joint development activities involving medical device software
  • What are the hurdles for patent counsel to demonstrate a software-related claim is not abstract?
  • What guidance have the courts provided in recent decisions concerning patent eligibility for software-related inventions?
  • What factors should counsel consider when determining what type of IP protection to seek?